NCT02312011 - A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions

Myotonic Dystrophy Type 1

Interventions

DRUG

IONIS-DMPKRx

Drug

DRUG

Placebo

Trial Locations (8)

University of Rochester, Rochester

Kennedy Krieger Institute, Baltimore

University of Florida, Gainesville

The Ohio State University, Columbus

University of Kansas Medical Center, Kansas City

Houston Methodist, Houston

University of Utah, Salt Lake City

Stanford University Medical Center, Stanford